Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verastem (VSTM) Research & Development (2018 - 2025)

Verastem (VSTM) has 8 years of Research & Development data on record, last reported at $31.7 million in Q4 2025.

  • For Q4 2025, Research & Development rose 52.19% year-over-year to $31.7 million; the TTM value through Dec 2025 reached $114.6 million, up 40.9%, while the annual FY2025 figure was $114.6 million, 40.9% up from the prior year.
  • Research & Development reached $31.7 million in Q4 2025 per VSTM's latest filing, up from $29.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $31.7 million in Q4 2025 and bottomed at $8.9 million in Q1 2021.
  • Average Research & Development over 5 years is $17.4 million, with a median of $14.4 million recorded in 2022.
  • Peak YoY movement for Research & Development: fell 18.56% in 2021, then surged 109.52% in 2023.
  • A 5-year view of Research & Development shows it stood at $11.4 million in 2021, then decreased by 5.76% to $10.7 million in 2022, then soared by 109.52% to $22.5 million in 2023, then dropped by 7.51% to $20.8 million in 2024, then skyrocketed by 52.19% to $31.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $31.7 million in Q4 2025, $29.0 million in Q3 2025, and $24.8 million in Q2 2025.